Gharbin John, Winful Adwoa, Hassan Mubariz Ahmed, Bajaj Siddharth, Batta Yashvardhan, Alebna Pamela, Rhodd Suchellis, Taha Mohammed, Fatima Urooj, Mehrotra Prafulla
Department of Medicine, Howard University Hospital, Washington DC, USA.
Department of Hospital Medicine, Doctors Hospital of Augusta, Augusta, GA, USA.
Curr Probl Cardiol. 2023 May;48(5):101609. doi: 10.1016/j.cpcardiol.2023.101609. Epub 2023 Jan 21.
Heart Failure (HF) and Opioid Use Disorder (OUD) independently have significant impact on patients and the United States (US) health system. In the setting of the opioid epidemic, research on the effects of OUD on cardiovascular diseases is rapidly evolving. However, no study exists on differential outcomes of ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM) in patients with HF with OUD. We performed a retrospective, observational cohort study using National Inpatient Sample (NIS) 2018-2020 databases. Patients aged 18 years and above with diagnoses of HF with concomitant OUD were included. Patients were further classified into ICM and NICM. Primary outcome of interest was differences in all- cause in-hospital mortality. Secondary outcome was incidence of cardiogenic shock. We identified 99,810 hospitalizations that met inclusion criteria, ICM accounted for 27%. Mean age for ICM was higher compared to NICM (63 years vs 56 years, P < 0.01). Compared to NICM, patients with ICM had higher cardiovascular disease risk factors and comorbidities; type 2 diabetes mellitus (46.3 % vs 30.1%, P < 0.01), atrial fibrillation/flutter (33.5% vs 29.9%, P < 0.01), hyperlipidemia (52.5% vs 28.9%, P < 0.01), and Charlson comorbidity index ≥5 was 46.7% versus 29.7%, P < 0.01. After controlling for covariates and potential confounders, we observed higher odds of all-cause in-hospital mortality in patients with NICM (aOR = 1.36; 95% CI:1.03-1.78, P = 0.02). There was no statistical significant difference in incidence of cardiogenic shock between ICM and NICM (aOR = 0.86;95% CI 0.70-1.07, P = 0.18). In patients with HF with concomitant OUD, we found a 36% increase in odds of all-cause in-hospital mortality in patients with NICM compared to ICM despite being younger in age with less comorbidities. There was no difference in odds of in-hospital cardiogenic shock in this study population. This study contributes to the discussion of OUD and cardiovascular diseases which is rapidly developing and requires further prospective studies.
心力衰竭(HF)和阿片类物质使用障碍(OUD)分别对患者和美国医疗系统产生重大影响。在阿片类物质流行的背景下,关于OUD对心血管疾病影响的研究正在迅速发展。然而,目前尚无关于合并OUD的心力衰竭患者中缺血性心肌病(ICM)和非缺血性心肌病(NICM)不同结局的研究。我们使用2018 - 2020年国家住院样本(NIS)数据库进行了一项回顾性观察队列研究。纳入年龄在18岁及以上、诊断为合并OUD的HF患者。患者进一步分为ICM和NICM。感兴趣的主要结局是全因住院死亡率的差异。次要结局是心源性休克的发生率。我们确定了99810例符合纳入标准的住院病例,其中ICM占27%。ICM的平均年龄高于NICM(63岁对56岁,P < 0.01)。与NICM相比,ICM患者有更高的心血管疾病危险因素和合并症;2型糖尿病(46.3%对30.1%,P < 0.01)、心房颤动/扑动(33.5%对29.9%,P < 0.01)、高脂血症(52.5%对28.9%,P < 0.01),Charlson合并症指数≥5分别为46.7%和29.7%,P < 0.01。在控制协变量和潜在混杂因素后,我们观察到NICM患者全因住院死亡率的几率更高(校正比值比[aOR] = 1.36;95%置信区间[CI]:1.03 - 1.78,P = 0.02)。ICM和NICM在心源性休克发生率方面无统计学显著差异(aOR = 0.86;95% CI 0.70 - 1.07,P = 0.18)。在合并OUD的HF患者中,我们发现与ICM相比,NICM患者全因住院死亡率的几率增加了36%,尽管其年龄更小且合并症更少。在该研究人群中,住院心源性休克的几率没有差异。这项研究有助于对正在迅速发展且需要进一步前瞻性研究的OUD与心血管疾病的讨论。